A six-month clinical trial found that a supplement combining citrus and grape extracts, hesperidin, and chromium significantly reduced fasting blood glucose in prediabetic adults. Participants also ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Scientists discovered that a blood molecule called CtBP2 may play a major role in how we age. It helps regulate metabolism ...

After being diagnosed with type 2 diabetes, Eric Dodson turned to tea—not just as a drink, but as a lifeline. His journey led to the creation of Cuples Tea House, where wellness and community steep ...

A little-known desert berry may hold the key to fighting diabetes. Scientists may have uncovered a surprising new weapon in the fight against diabetes: the fruit of an ancient desert plant. Known as ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Could slightly elevated blood sugar levels lead to serious health problems in the future? A single patient's question sparked ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

The clinical hold follows Intellia's disclosure that it paused dosing in two Phase III trials after a patient experienced a serious adverse event.

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...